International Cannabis Weekly: 145

• Mexico considers cannabis legalisation to boost economy after COVID-19.
• Dutch residents are smoking more cannabis under lockdown, finds preliminary study.
• New Brunswick’s legal cannabis retailer reports record profits as residents stockpile.
• UK Food Standards Agency will not postpone CBD deadline in light of COVID-19.
• Colombia’s Sannabis halts hemp exports to the US amid pandemic delays.

• New Zealand releases final cannabis legislation ahead of referendum.
• Poland’s agriculture ministry recommends raising hemp THC levels to 1%.
• DEA lawsuit reveals US cannabis research policy violated international treaties.

• German medical cannabis imports show little growth in early 2020.
• Italy’s agriculture undersecretary calls for more clarity on hemp regulations
• Cantourage begins supplying dronabinol to the German cannabis market.
• Althea Group signs partnership with Nimbus Health to supply the German market
• North Macedonia seeks Medivie executives over criminal connection allegations.

• CIBC reduces 2020 recreational cannabis sales forecast to US$1.8 billion.
• Saskatchewan begins accepting cannabis retail applications for small communities.
• Canopy Growth to lay off 200 additional workers in latest cost-cutting measure.

• Virginia governor signs bill to regulate hemp-derived CBD in food.
• Essential business status marks an unprecedented turnaround for cannabis.
• Prohibition Partners LIVE announces ProCapital, in partnership with MAZAKALI.
• Denver cannabis advisory group to review social equity and diversity issues.
• Kansas governor says legal medical cannabis remains a possibility in 2020.
• Cannabis wholesale prices fall in Michigan after change in cannabis sales law.
• High Times acquires 13 California dispensaries from Harvest Health & Recreation.
• Cresco Labs pulls out of US$282.5 million acquisition of Tryke.

• Australian government releases proposal to make CBD available over-the-counter.
• MediPharm Labs signs international white-label supply deal with Helius Therapeutics.

• Brazil approves first medical cannabis product under new regulations
• Tree of Knowledge International begins trading on the Jamaica Stock Exchange
• US Virgin Islands revises cannabis bill to raise tax revenues amid coronavirus.

• Labat Africa to sell 150 million shares to fund medical cannabis expansion.
• Lesotho’s Canna-Q seeks investors to launch commercial cannabis project.
• South Africa’s health authority unlikely to grant licences during lockdown.

• Scientists develop new, long-term method for storing cannabis pollen.
• Meta-study finds cannabis reduces opioid use in chronic pain patients.
• ‘No convincing evidence’ that smoking cannabis leads to chronic pulmonary disease.

• Champignon Brands announced as headline partner for PSYCH
• Oregon psilocybin legalisation campaign begins new signature collection strategy
• Soap company Dr. Bronner’s donates US$1 million to Oregon’s psilocybin campaign
• COMPASS Pathways completes US$80 million Series B investment round
• Orthogonal Thinker closes US$6 million seed funding round.
• Hollister Biosciences closes acquisition of AlphaMind Brands.

Prohibition Partners is proud to launch The Oceania Cannabis Report: Second Edition. The report contains expert analysis on the latest industry developments across Australia, New Zealand and the surrounding islands, which is set to be worth $US1.55 billion by 2024.

Download your free copy of the report, here.